Search Press releases Keywords From To 25 Jun 2021 Disposals of own shares Read More 25 Jun 2021 UCB Receives Positive CHMP Opinion Recommending Approval of BIMZELX[®*] (bimekizumab) in the EU for the Treatment of Adults with Moderate to Severe Plaque Psoriasis Read More 18 Jun 2021 Disposals of own shares Read More 11 Jun 2021 Disposals of own shares Read More 4 Jun 2021 Disposals of own shares Read More 1 Jun 2021 EULAR 2021: New Data from UCB’s Rheumatology Portfolio Demonstrates Real World Value for Patients with axSpA, PsA, and Women of Childbearing Age Read More Pagination First page Previous page Previous … Page 33 Page 34 Page 35 Page 36 Current page 37 Page 38 Page 39 Page 40 Page 41 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
